International conference on SSP and systems of health in Africa Ouagadougou, 28 - April 30th, 2008

1. International conference on SSP and systems of health in Africa Ouagadougou, 28 - April 30th, 2008 Experience and progress of the Burkina Faso in incorporation of traditional medicine in the national system of health Professeur Jean-Baptiste NIKIEMA, PhD Manager of traditional medicine Member of the REC (WHO / AFRICAN)

2. Contents • Introduction • Institutionalization of MT • Main fruits of institutionalization • MT and revitalization of SSP

3. Introduction (1) • Profile relating to MT • 30.000 TPS • 01 TPS / 500 inhabitants • Naturothérapeutes, chemists, obstetricians trad ., etc. • TPS = leader of the community and regulator • TPS, a conservative of traditional medical knowledge and an innovator

4. Introduction (2) • Profile (suite) • Belt of Cassias (sennas) • 2000 medical plants listed among which 200 of the popular usage (malnutrition, family planning, paludism, sickle cell anemia, etc) • Business figure: more than 20 million dollars US • Remarkable peculiarities (structural and pharmacologic originalities)

5. Introduction (3) • system of health • Modern medicine (MM): conventional (first appeal: 30 %) • Pb of company • Traditional medicine (MT): alternative (first appeal: 70 %) • Pb of norms and standardization, • weak material. risks of correlations and delay in the taking care of the patients importance of institutionalization and incorporation of MT

6. Institutionalization of MT

7. Institutionalization of MT (1) • Agreements and international commitments (1) • Statement of Alma Ata (1978): role of MT in the care of primary health • Convention on biodiversity (1992): conservation of diversity, lasting use and equitable distribution of consequences • Strategy of the WHO / AFRICAN (2000): promotion of the role of MT in the national systems of health

8. Institutionalization of MT (2) • Agreements and international commitments (2) -Statement of Lusaka (2001): decade of MT in Africa (2001-2010) -Statement of Abuja (2001): research on MT, a preference in Africa -Statement of Maputo (2003): protection and promotion of African creations in medicaments

9. Institutionalization of MT (3) • Methodology -advocacy (WHO, UA, researchers) -political will - participation of TPS, researchers, doctors, chemists -general agreement of the partners Elaboration of texts, adoption by the Government and the Parliament

10. Institutionalization of MT (4) • National policy (2004) -Assure a good financial year of MT - Ameliorate the local production of medicaments -Regulate working and exportation of the curative plants -Reinforce the competence of TPS - Reinforce research on MT -Augment financing of MT -Ameliorate the collaboration MM / MT

11. Institutionalization of MT (5) • Legislative and regulation situation -Law (1996) -Regulation of the financial year of MT (2004) -Regulation of the approval of traditional medicaments (2004) -Code of practice of TPS of Burkina (2007)

12. Main Fruits of institutionnalisation

13. Fruits of institutionnalisation (1) • Structuring of MT -Direction of MT -National Council of TPS of BF -Associations of TPS -Technical commission of approval

14. Fruits of institutionnalisation (2) • Collaboration MM / MT -structures of interface MT / mm -frame of cooperation between health workers and TPS -Notification of diseases with obligatory statement (TB, PFA, Measles, Yellow Fever, etc)

15. Fruits of institutionalization (3) • Local production • 04 normalized production units • 11 approved medicaments • 04 medicaments inscribed on LNME • Assured quality control • Modules of training of TPS on good practices

16. Fruits of institutionalization (4) • Scientific research • 04 research centres • Persons means: critical mass achieves for the development of medicaments • clinical tries (sickle cell anemia, paludism, HIV / AIDS) • Annual workshop of restitution and biannuel Congress of herbal medicine (CIPO)

17. Fruits de l’institutionnalisation (5) • Partenariat • Associations de TPS • ONGs (GERES, Jardins du monde, prométra, réjométra, récipréna, etc.) • OMS • CAMES • OAPI

18. Fruits de l’institutionnalisation (5) • Financement de la MT • état (100.000 dollars par an) • ONG

19. Exemples de médicaments produits au Burkina Faso

20. Cochlospermum tinctorium Catégorie 2 Traitement du paludisme simple

21. Zanthoxylum xanthoxyloides Catégory 2 • Treatment of the sickle cell anemia • Isolation and identification of original molecules (Burkinabines A, B, C) • antifalcémiantes ownership

22. Euphorbiahirta Category 2 Category 3 Treatment of the amoebic diarrhea

23. Moringa oleifera Category 1 (Popular) • 1.Purification of water • 2. Food supplementary benefit • (vitamins and • antibacterial proteins)

24. Calotropis procera Category (ongoing) 4 • breast carcinoma • (Cardenolids related • Compound)

25. Spirulina platensis)Catégory 2 (popular

26. Use of Spirulina platensis • nutritional recovery • Malnutris children • PvVIH (recovery immunologique) • Students • Seniors

27. MT and revitalization of SSP what is to be done?

28. Normalisation of MT • Material -Practice -Harmlessness and effectiveness -Techniques of standardization and industrial production -Good practices of cultures of the curative plants

29. Promotion of the place of TPS • Leader of the community • Agent of sensitization (IEC) • Partner of the system of health Importance of literacy tuition and training

30. New challenges • Review of the national policies of MT; • Inscription of traditional medicaments approved on LNME • Education of MT in the schools of training

31. THANK YOU